WELCOME to epgonline.org

Welcome to epgonline.org, a free online source of credible and independent scientific content intended for healthcare professionals in the United Kingdom that brings all the medical information you need into one place, providing education and guidance to help with the diagnosis and treatment of your patients.

This website provides:

  • Drug information, categorised using the ATC Classification System, providing indication, dosage, administration and precautions.
  • Specialty and disease information, categorising specialties and diseases using the ICD-10 classification, with further insight found in the Disease Focus area.
  • The Horizons series of articles, written by our team of specialists, that ask what the future of healthcare holds, evaluating emerging trends to provide expert insight.
  • The latest news to keep you up-to-date with current advancements in drug development, advocacy and awareness, industry mergers and acquisitions, clinical trial progression and congress information.
  • Recent opinion articles shared with us by healthcare professionals to express their views and experiences.
  • A wide variety of accredited internal and external CME modules and courses, designed to educate on the latest care strategies for specific conditions.
  • The latest studies, trials and guidelines from global publications provide a comprehensive collection of current and past developments in medicine, helping you to provide best practice.
  • Medical applications that deliver creative solutions to aid in the diagnosis and treatment of your patients.
  • Specialist educational microsites, or Learning Zones, each devoted to self-directed medical education surrounding a specific disease, condition or procedure.

Registration is quick and simple, giving you unlimited access to all content and features, allowing you to save pages, comment on your favourite articles and access the personalised dashboard.

Latest News

Added 21 hours ago Drug news

Phase III efficacy study of CAM 2038 meets endpoints in chronic low back pain.- Camurus.

Camurus announced positive results from a Phase III efficacy study of CAM 2038, weekly and monthly buprenorphine depots, in opioid...

Added 21 hours ago Drug news

BORA trial shows long-term safety and efficacy of Fasenra in patients with eosinophilic asthma.-AstraZeneca

AstraZeneca announced results from the BORA Phase III extension trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as...

Added 21 hours ago Drug news

Phase III trial of ZP 4207 meets primary endpoint in severe hypoglycemia in diabetes.- Zealand Pharma.

Zealand Pharma announced it has achieved primary and key secondary endpoints in the pivotal Phase III trial with ZP 4207...

Selected congress insight

The Asthma Report

ERS 2018 | Day 1 Highlights

Posted 3 days ago

News and insight from our reporting team at ERS 2018, who looked at one of the sessions covering novel pharmacological therapies in airway disease. 

The Asthma Report

ERS 2018 | Day 2 Highlights

Posted 4 days ago

A summary of the sessions from the State of the art airways programme at the European Respiratory Society Congress 2018.

Antithrombosis News

ESC 2018: Antithrombosis News congress highlights

Posted 22 days ago

Follow us on Facebook or Twitter now to get more ESC 2018 highlights and congress reports.

Antithrombosis News

ESC 2018 Day 1 highlights: National prescribing and adverse event rates of patients at risk of stroke with non-valvular AF.

Posted 26 days ago

Stroke prevention for patients with non-valvular atrial fibrillation is a key topic at ESC 2018. Follow us on Facebook or Twitter now to get more ESC 2018 highlights and congress reports.